Department Of Health
Details
JCVI advises children aged 6 months to 4 years in a clinical risk group should be offered 2 3-microgram doses of the Pfizer-BioNTech COVID-19 vaccine.
Further advice regarding a potential third 3-microgram dose of the Pfizer-BioNTech COVID-19 vaccine will be issued in due course.
JCVI does not currently advise COVID-19 vaccination of children aged 6 months to 4 years who are not in a clinical risk group.
JCVI has previously offered advice regarding the vaccination of children aged 5 to 11.